Editorial Board for section 'Plasma Cell Disorders'

Please see the section webpage for more information on this section.

Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.

Members


Website
Section Editor-in-Chief
Service d'Hématologie, Hôpital Pitié Salpêtrière, 47‐83 boulevard de l'hôpital, F‐75013 Paris, France
Interests: myeloma; AL amyloidosis; monoclonal gammopathy of clinical significance; POEMS; transplantation
Special Issues, Collections and Topics in MDPI journals
Inserm UMRS 938, Saint Antoine Hospital, Sorbonne Université, Paris, France
Interests: renal complications of monoclonal immunoglobulins; monoclonal immunoglobulin deposition diseases; light chain deposition disease; heavy chain deposition disease; myeloma cast nephropathy; adult Fanconi’s syndrome; cryoglobulin; monoclonal gammopathy of renal significance (MGRS); monoclonal gammopathy of clinical significance (MGCS); structure and biochemical properties of monoclonal immunoglobulins

Website
Section Board Member
Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic de Barcelona, Barcelona, Spain
Interests: monoclonal gammopathies; multiple myeloma; amyloidosis
Prof. Dr. Gordon Cook
Website
Section Board Member
Section of Experimental Haematology, Leeds Institute of Cancer & Pathology, University of Leeds, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK
Interests: multiple myeloma; clinical trial design and delivery; tumour immunology & immunotherapy

Website
Section Board Member
IUC-Oncopole, Centre de Recherche en Cancérologie de Toulouse INSERMU1037, Toulouse, France
Interests: multiple myeloma; genomic; prognosis; minimal residual disease; microenvironment
Department of Hematology, University Hospital Leuven, Leuven, Belgium
Interests: multiple myeloma; new drugs; adverse events; quality of life; drug resistance; AL amyloidosis
Special Issues, Collections and Topics in MDPI journals
Department of Stem Cell Transplantation, UKE, 20246 Hamburg, Germany
Interests: stem cell biology in myelofibrosis; allogeneic stem cell transplantation from unrelated donors; prevention and treatment of the donor-to-host response; cellular immunotherapy with genetically modified stem cells and T cells (CAR T cells); detection of minimal residual disease; molecular genetics in myeloid diseases; multiple myeloma; myelodysplastic syndromes
Special Issues, Collections and Topics in MDPI journals
Prof. Dr. Giovanni Palladini
Website
Section Board Member
Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Viale Golgi, 19, 27100 Pavia, Italy
Interests: amyloidosis; monoclonal gammopathies of clinical significance; biomarkers
Special Issues, Collections and Topics in MDPI journals

Website
Section Board Member
Sorbonne Université, INSERM U938, Centre de Recherche Saint-Antoine, F-75012 Paris, France
Interests: cancer; myeloma; mesenchymal stem cells; signaling pathways; differenciation
Special Issues, Collections and Topics in MDPI journals

Website
Section Board Member
1. Oslo Myeloma Center, Oslo University Hospital, Oslo, Norway
2. KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway
Interests: clinical studies in myeloma; PET-CT; MRD-driven trials
Special Issues, Collections and Topics in MDPI journals
Amyloidosis Center and Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
Interests: local and systemic amyloidosis; genetic of plasma cell dyscrasias; monoclonal gammopathies of clinical significance; auto and allo transplantation
Special Issues, Collections and Topics in MDPI journals
Department of Clinical Therapeutics, School of Medicine, University of Athens, Athens, Greece
Interests: multiple myeloma; bone marrow; hematological malignancies; hematologic diseases; fracture; osteoporosis; bone biology; bone metabolism; myelodysplastic syndromes
Special Issues, Collections and Topics in MDPI journals
Cancer Center Amsterdam, Department of Hematology, Vrije Universiteit Amsterdam, Amsterdam UMC, 1081 HV Amsterdam, The Netherlands
Interests: multiple myeloma; immunotherapy; CD38-targeting antibodies; bispecific antibodies; plasma cell leukemia; MGUS

Website
Section Board Member
Seragnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
Interests: imaging in multiple myeloma; minimal residual disease; treatment of transplant eligible patients; phase III protocols
Back to TopTop